Sati Poly (SATIPOLY)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 1.94 is exceptionally low, suggesting the market has priced in heavy pessimism.
• Sales growth of 14.17% shows the company's products still have demand traction.
• ROCE of 39.33% points to strong capital efficiency if earnings normalize.
• Promoter holding of 63.01% aligns management's interests with minority shareholders.

Concerns

• Profit growth of -76.97% and a latest quarter net profit of only ₹1 Cr on ₹166 Cr sales indicate severe margin compression.
• Piotroski F-Score of 4/9 signals weak financial health and higher bankruptcy risk.
• No dividend (0%) means shareholders get no income while waiting for a recovery.
• The stock has dropped from ₹88.25 to ₹34, and with no book value data, the downside is hard to estimate.

AI Analysis

At ₹34, Sati Poly is being offered at a P/E of just 1.94, which would make any value investor sit up and take notice. But Benjamin Graham taught me that the cheapest stock can often be a trap in disguise. Sales are up 14.17%, yet profits have collapsed by 76.97%. That tells me the business is growing its top line but bleeding margins. The latest quarter says it all: ₹166 Cr of sales produced just ₹1 Cr of net profit—a hair-thin margin that would make any manufacturer wince. The market cap is only ₹24 Cr, so the stock has fallen from ₹88.25 to ₹34, near its 52-week low. The high ROCE of 39.33% suggests the underlying capital efficiency is decent, but without book value or debt data, I'm flying partially blind. The Piotroski F-Score of 4 out of 9 reinforces my caution—this is not a financially strong company right now. Promoter holding at 63.01% is comforting; they are in the same boat as us. But a 0% dividend yield means we're relying entirely on capital appreciation, and with profits this weak, that's a leap of faith. The PEG of 0.14 looks alluring, but it's based on sales growth, not earnings growth—and profits are falling, not rising. This is not a stalwart or a fast grower. It's a classic turnaround candidate, but only if margins recover. I would not rush in. I'd watch the next two quarters for evidence that profit margins are healing before committing a single rupee. A cheap stock that stays cheap is not a bargain; it's an opportunity cost.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer